Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | elastase, neutrophil expressed | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | transmembrane protease serine 3 | elastase, neutrophil expressed | 267 aa | 236 aa | 27.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Fatty acid synthase homolog | 0.0798 | 0.945 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.044 | 0.4341 | 0.5814 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0179 | 0.0613 | 0.082 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0354 | 0.3106 | 0.4127 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0139 | 0.0042 | 0.0056 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.029 | 0.22 | 0.2947 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0252 | 0.165 | 0.221 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.044 | 0.4341 | 0.4341 |
Mycobacterium ulcerans | thioesterase | 0.0369 | 0.3323 | 0.4451 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0354 | 0.3106 | 0.416 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0659 | 0.7467 | 1 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0287 | 0.2157 | 0.2601 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0354 | 0.3106 | 0.416 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0315 | 0.2556 | 0.3746 |
Mycobacterium ulcerans | thioesterase TesA | 0.0369 | 0.3323 | 0.4451 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0467 | 0.4734 | 0.634 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0359 | 0.3189 | 0.4272 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0413 | 0.3962 | 0.5306 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0659 | 0.7467 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.029 | 0.22 | 0.2947 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0429 | 0.4183 | 0.5602 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0413 | 0.3962 | 0.3907 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0467 | 0.4734 | 0.634 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0467 | 0.4734 | 0.634 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0659 | 0.7467 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.044 | 0.4341 | 0.579 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0467 | 0.4734 | 1 |
Loa Loa (eye worm) | fatty acid synthase | 0.0437 | 0.4293 | 0.4338 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.044 | 0.4341 | 0.5814 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0429 | 0.4183 | 0.5602 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0467 | 0.4734 | 0.6319 |
Mycobacterium ulcerans | polyketide synthase | 0.044 | 0.4341 | 0.5814 |
Mycobacterium ulcerans | polyketide synthase | 0.0467 | 0.4734 | 0.634 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.015 | 0.0194 | 0.0259 |
Onchocerca volvulus | 0.077 | 0.9057 | 0.9285 | |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0369 | 0.3323 | 0.4451 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0318 | 0.2597 | 0.3478 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0467 | 0.4734 | 0.634 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.044 | 0.4341 | 0.5814 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.044 | 0.4341 | 0.579 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.044 | 0.4341 | 0.5814 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0369 | 0.3323 | 0.4419 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0467 | 0.4734 | 0.6319 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.044 | 0.4341 | 0.5814 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 0.1562 | 0.078 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0467 | 0.4734 | 0.634 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.029 | 0.22 | 0.2907 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0659 | 0.7467 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0413 | 0.3962 | 0.3962 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.044 | 0.4341 | 0.5814 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0467 | 0.4734 | 0.6319 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0139 | 0.0042 | 0.0056 |
Loa Loa (eye worm) | hypothetical protein | 0.0741 | 0.8638 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.044 | 0.4341 | 0.5814 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 89 nM | The compound was tested in vitro for ability to inhibit human leukocyte elastase activity | ChEMBL. | 7932532 |
Ki (binding) | = 89 nM | The compound was tested in vitro for ability to inhibit human leukocyte elastase activity | ChEMBL. | 7932532 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.